nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—Blood pressure increased—Sorafenib—liver cancer	0.016	0.0413	CcSEcCtD
Pyridostigmine—Dry skin—Sorafenib—liver cancer	0.0107	0.0275	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—liver cancer	0.0101	0.026	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—liver cancer	0.00932	0.024	CcSEcCtD
Pyridostigmine—Epistaxis—Sorafenib—liver cancer	0.00846	0.0218	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—liver cancer	0.00767	0.0198	CcSEcCtD
Pyridostigmine—Alopecia—Sorafenib—liver cancer	0.00711	0.0183	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—liver cancer	0.0071	0.0183	CcSEcCtD
Pyridostigmine—Muscle spasms—Sorafenib—liver cancer	0.00673	0.0174	CcSEcCtD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00655	0.0107	CbGpPWpGaD
Pyridostigmine—Lacrimation increased—Epirubicin—liver cancer	0.00643	0.0166	CcSEcCtD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—GLUL—liver cancer	0.00624	0.0102	CbGpPWpGaD
Pyridostigmine—Loss of consciousness—Sorafenib—liver cancer	0.00616	0.0159	CcSEcCtD
Pyridostigmine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00613	0.01	CbGpPWpGaD
Pyridostigmine—Neck pain—Epirubicin—liver cancer	0.00599	0.0155	CcSEcCtD
Pyridostigmine—Myalgia—Sorafenib—liver cancer	0.00596	0.0154	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—liver cancer	0.00595	0.0153	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—liver cancer	0.00575	0.0148	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—BCL2L1—liver cancer	0.00558	0.00912	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—GLUL—liver cancer	0.00557	0.0091	CbGpPWpGaD
Pyridostigmine—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00555	0.00906	CbGpPWpGaD
Pyridostigmine—Neck pain—Doxorubicin—liver cancer	0.00555	0.0143	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00547	0.00894	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00533	0.00872	CbGpPWpGaD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—liver cancer	0.00532	0.0137	CcSEcCtD
Pyridostigmine—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00531	0.00867	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—MAPK14—liver cancer	0.00528	0.00863	CbGpPWpGaD
Pyridostigmine—Pulmonary oedema—Epirubicin—liver cancer	0.00527	0.0136	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00521	0.0134	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—liver cancer	0.00519	0.0134	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—ESR1—liver cancer	0.00518	0.00847	CbGpPWpGaD
Pyridostigmine—Thrombophlebitis—Epirubicin—liver cancer	0.00497	0.0128	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—liver cancer	0.00488	0.0126	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—liver cancer	0.0048	0.0124	CcSEcCtD
Pyridostigmine—ACHE—Neuronal System—GLUL—liver cancer	0.00478	0.00781	CbGpPWpGaD
Pyridostigmine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00476	0.00778	CbGpPWpGaD
Pyridostigmine—Eye pain—Epirubicin—liver cancer	0.00476	0.0123	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Sorafenib—liver cancer	0.00468	0.0121	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—liver cancer	0.00459	0.0118	CcSEcCtD
Pyridostigmine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00457	0.00747	CbGpPWpGaD
Pyridostigmine—Urticaria—Sorafenib—liver cancer	0.00454	0.0117	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of proteins—ADAMTS17—liver cancer	0.00453	0.00741	CbGpPWpGaD
Pyridostigmine—Abdominal pain—Sorafenib—liver cancer	0.00452	0.0117	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—liver cancer	0.00441	0.0114	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—liver cancer	0.00439	0.0113	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—MMP2—liver cancer	0.00434	0.00709	CbGpPWpGaD
Pyridostigmine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00434	0.00708	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—GLUL—liver cancer	0.00427	0.00697	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00425	0.00695	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00423	0.00691	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Sorafenib—liver cancer	0.00421	0.0109	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.0042	0.00685	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00417	0.00682	CbGpPWpGaD
Pyridostigmine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00415	0.00678	CbGpPWpGaD
Pyridostigmine—Asthenia—Sorafenib—liver cancer	0.0041	0.0106	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—TNF—liver cancer	0.0041	0.00669	CbGpPWpGaD
Pyridostigmine—Cardiac arrest—Epirubicin—liver cancer	0.00409	0.0105	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—liver cancer	0.00406	0.0105	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—ADAMTS17—liver cancer	0.00405	0.00661	CbGpPWpGaD
Pyridostigmine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00399	0.00651	CbGpPWpGaD
Pyridostigmine—Dry skin—Epirubicin—liver cancer	0.00394	0.0102	CcSEcCtD
Pyridostigmine—Diarrhoea—Sorafenib—liver cancer	0.00391	0.0101	CcSEcCtD
Pyridostigmine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00383	0.00626	CbGpPWpGaD
Pyridostigmine—Cardiac arrest—Doxorubicin—liver cancer	0.00378	0.00975	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00374	0.00612	CbGpPWpGaD
Pyridostigmine—Abdominal distension—Epirubicin—liver cancer	0.00374	0.00964	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—liver cancer	0.00372	0.00958	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—liver cancer	0.00365	0.0094	CcSEcCtD
Pyridostigmine—Vomiting—Sorafenib—liver cancer	0.00364	0.00937	CcSEcCtD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00363	0.00593	CbGpPWpGaD
Pyridostigmine—Rash—Sorafenib—liver cancer	0.0036	0.00929	CcSEcCtD
Pyridostigmine—Dermatitis—Sorafenib—liver cancer	0.0036	0.00928	CcSEcCtD
Pyridostigmine—Headache—Sorafenib—liver cancer	0.00358	0.00923	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—liver cancer	0.00357	0.00921	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—liver cancer	0.00346	0.00892	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—liver cancer	0.00344	0.00886	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of proteins—YIF1A—liver cancer	0.00344	0.00561	CbGpPWpGaD
Pyridostigmine—Pollakiuria—Epirubicin—liver cancer	0.00343	0.00885	CcSEcCtD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00343	0.0056	CbGpPWpGaD
Pyridostigmine—Nausea—Sorafenib—liver cancer	0.0034	0.00875	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—CCND1—liver cancer	0.00336	0.00549	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—JUN—liver cancer	0.00335	0.00548	CbGpPWpGaD
Pyridostigmine—Drowsiness—Epirubicin—liver cancer	0.00331	0.00854	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—liver cancer	0.00331	0.00852	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—liver cancer	0.00318	0.00819	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—MAPK8—liver cancer	0.00317	0.00518	CbGpPWpGaD
Pyridostigmine—Epistaxis—Epirubicin—liver cancer	0.00312	0.00806	CcSEcCtD
Pyridostigmine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.00312	0.00509	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—YIF1A—liver cancer	0.00307	0.00501	CbGpPWpGaD
Pyridostigmine—Drowsiness—Doxorubicin—liver cancer	0.00307	0.0079	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—liver cancer	0.00303	0.00781	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—liver cancer	0.00296	0.00763	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—liver cancer	0.00289	0.00745	CcSEcCtD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00285	0.00465	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—EXOSC2—liver cancer	0.00283	0.00462	CbGpPWpGaD
Pyridostigmine—Bradycardia—Doxorubicin—liver cancer	0.0028	0.00722	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00274	0.00448	CbGpPWpGaD
Pyridostigmine—Hypoaesthesia—Doxorubicin—liver cancer	0.00274	0.00706	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.0027	0.00442	CbGpPWpGaD
Pyridostigmine—Alopecia—Epirubicin—liver cancer	0.00263	0.00678	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00261	0.00426	CbGpPWpGaD
Pyridostigmine—Flatulence—Epirubicin—liver cancer	0.00255	0.00658	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—EXOSC2—liver cancer	0.00252	0.00412	CbGpPWpGaD
Pyridostigmine—Muscle spasms—Epirubicin—liver cancer	0.00249	0.00642	CcSEcCtD
Pyridostigmine—ACHE—Peptide hormone metabolism—CTNNB1—liver cancer	0.00248	0.00406	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CG—liver cancer	0.00248	0.00406	CbGpPWpGaD
Pyridostigmine—Alopecia—Doxorubicin—liver cancer	0.00243	0.00627	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00241	0.00394	CbGpPWpGaD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00238	0.00389	CbGpPWpGaD
Pyridostigmine—Agitation—Epirubicin—liver cancer	0.00238	0.00613	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—liver cancer	0.00236	0.00609	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00235	0.00384	CbGpPWpGaD
Pyridostigmine—Vertigo—Epirubicin—liver cancer	0.00233	0.006	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00233	0.0038	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.0023	0.00376	CbGpPWpGaD
Pyridostigmine—Muscle spasms—Doxorubicin—liver cancer	0.0023	0.00594	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—liver cancer	0.00228	0.00587	CcSEcCtD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00227	0.00371	CbGpPWpGaD
Pyridostigmine—Convulsion—Epirubicin—liver cancer	0.00224	0.00578	CcSEcCtD
Pyridostigmine—BCHE—Peptide hormone metabolism—CTNNB1—liver cancer	0.00222	0.00362	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CG—liver cancer	0.00221	0.00362	CbGpPWpGaD
Pyridostigmine—Myalgia—Epirubicin—liver cancer	0.0022	0.00568	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—liver cancer	0.0022	0.00568	CcSEcCtD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CD—liver cancer	0.00218	0.00357	CbGpPWpGaD
Pyridostigmine—Vertigo—Doxorubicin—liver cancer	0.00215	0.00555	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—liver cancer	0.00213	0.00549	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—liver cancer	0.00211	0.00543	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—liver cancer	0.00208	0.00535	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00206	0.00337	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.00205	0.00334	CbGpPWpGaD
Pyridostigmine—Hyperhidrosis—Epirubicin—liver cancer	0.00204	0.00527	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—liver cancer	0.00204	0.00526	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—IL6—liver cancer	0.00203	0.00331	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.00202	0.00331	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00199	0.00326	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—UGDH—liver cancer	0.00199	0.00325	CbGpPWpGaD
Pyridostigmine—Hypotension—Epirubicin—liver cancer	0.00197	0.00509	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—liver cancer	0.00197	0.00508	CcSEcCtD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00197	0.00322	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CD—liver cancer	0.00195	0.00318	CbGpPWpGaD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00193	0.00496	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00191	0.00313	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CB—liver cancer	0.0019	0.00311	CbGpPWpGaD
Pyridostigmine—Paraesthesia—Epirubicin—liver cancer	0.0019	0.00489	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—liver cancer	0.00189	0.00487	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—liver cancer	0.00188	0.00484	CcSEcCtD
Pyridostigmine—ACHE—Metabolism—EPT1—liver cancer	0.00187	0.00305	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00187	0.00305	CbGpPWpGaD
Pyridostigmine—Hypotension—Doxorubicin—liver cancer	0.00183	0.00471	CcSEcCtD
Pyridostigmine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.00182	0.00297	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.00179	0.00292	CbGpPWpGaD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00178	0.00459	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00178	0.00291	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—UGDH—liver cancer	0.00177	0.0029	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—TAT—liver cancer	0.00177	0.00289	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.00177	0.00288	CbGpPWpGaD
Pyridostigmine—Paraesthesia—Doxorubicin—liver cancer	0.00176	0.00453	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00174	0.00285	CbGpPWpGaD
Pyridostigmine—Feeling abnormal—Epirubicin—liver cancer	0.00174	0.00449	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—liver cancer	0.00174	0.00448	CcSEcCtD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.00173	0.00283	CbGpPWpGaD
Pyridostigmine—Gastrointestinal pain—Epirubicin—liver cancer	0.00173	0.00445	CcSEcCtD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CB—liver cancer	0.0017	0.00277	CbGpPWpGaD
Pyridostigmine—Urticaria—Epirubicin—liver cancer	0.00168	0.00433	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—liver cancer	0.00167	0.00431	CcSEcCtD
Pyridostigmine—BCHE—Metabolism—EPT1—liver cancer	0.00167	0.00272	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00165	0.0027	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.00164	0.00267	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00163	0.00267	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.00161	0.00264	CbGpPWpGaD
Pyridostigmine—Feeling abnormal—Doxorubicin—liver cancer	0.00161	0.00415	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—liver cancer	0.0016	0.00412	CcSEcCtD
Pyridostigmine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.0016	0.00261	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—ATF3—liver cancer	0.00159	0.0026	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—TAT—liver cancer	0.00158	0.00258	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Epirubicin—liver cancer	0.00156	0.00401	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00155	0.00254	CbGpPWpGaD
Pyridostigmine—Urticaria—Doxorubicin—liver cancer	0.00155	0.004	CcSEcCtD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.00155	0.00253	CbGpPWpGaD
Pyridostigmine—Abdominal pain—Doxorubicin—liver cancer	0.00155	0.00398	CcSEcCtD
Pyridostigmine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.00154	0.00251	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.00152	0.00249	CbGpPWpGaD
Pyridostigmine—Asthenia—Epirubicin—liver cancer	0.00152	0.00391	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.0015	0.00245	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.0015	0.00245	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.00145	0.00237	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Epirubicin—liver cancer	0.00145	0.00373	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—liver cancer	0.00144	0.00371	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—ATF3—liver cancer	0.00142	0.00232	CbGpPWpGaD
Pyridostigmine—Asthenia—Doxorubicin—liver cancer	0.0014	0.00362	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.00138	0.00225	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00135	0.0022	CbGpPWpGaD
Pyridostigmine—Vomiting—Epirubicin—liver cancer	0.00134	0.00346	CcSEcCtD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00134	0.00219	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Doxorubicin—liver cancer	0.00134	0.00345	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—liver cancer	0.00133	0.00343	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—liver cancer	0.00133	0.00343	CcSEcCtD
Pyridostigmine—ACHE—Neuronal System—BRAF—liver cancer	0.00133	0.00217	CbGpPWpGaD
Pyridostigmine—Headache—Epirubicin—liver cancer	0.00132	0.00341	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00131	0.00215	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00131	0.00214	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.0013	0.00213	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.0013	0.00212	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.00129	0.00211	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.00128	0.00209	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00127	0.00208	CbGpPWpGaD
Pyridostigmine—Nausea—Epirubicin—liver cancer	0.00126	0.00324	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—liver cancer	0.00124	0.0032	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.00124	0.00203	CbGpPWpGaD
Pyridostigmine—Rash—Doxorubicin—liver cancer	0.00123	0.00318	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—liver cancer	0.00123	0.00317	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—liver cancer	0.00122	0.00316	CcSEcCtD
Pyridostigmine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.00122	0.00199	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GLUL—liver cancer	0.0012	0.00197	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CPT1B—liver cancer	0.0012	0.00197	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—BRAF—liver cancer	0.00119	0.00194	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00116	0.0019	CbGpPWpGaD
Pyridostigmine—Nausea—Doxorubicin—liver cancer	0.00116	0.00299	CcSEcCtD
Pyridostigmine—ACHE—Metabolism—NR1H4—liver cancer	0.00116	0.0019	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CA—liver cancer	0.00116	0.00189	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00114	0.00187	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTA3—liver cancer	0.00114	0.00186	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—RAF1—liver cancer	0.00111	0.00181	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GLUL—liver cancer	0.00107	0.00175	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CPT1B—liver cancer	0.00107	0.00175	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.00105	0.00172	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.00105	0.00172	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTA4—liver cancer	0.00104	0.00171	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NR1H4—liver cancer	0.00104	0.00169	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CA—liver cancer	0.00103	0.00169	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00102	0.00167	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTA3—liver cancer	0.00102	0.00166	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTA2—liver cancer	0.00102	0.00166	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000992	0.00162	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—RAF1—liver cancer	0.00099	0.00162	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF2—liver cancer	0.000985	0.00161	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTA1—liver cancer	0.000982	0.0016	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000981	0.0016	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000978	0.0016	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000973	0.00159	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NAT2—liver cancer	0.000971	0.00159	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000933	0.00152	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTA4—liver cancer	0.000931	0.00152	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALDOB—liver cancer	0.000931	0.00152	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000911	0.00149	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00091	0.00149	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTA2—liver cancer	0.000908	0.00148	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000894	0.00146	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CRABP1—liver cancer	0.000888	0.00145	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF2—liver cancer	0.000879	0.00144	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTA1—liver cancer	0.000876	0.00143	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NAT2—liver cancer	0.000866	0.00141	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000865	0.00141	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000833	0.00136	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALDOB—liver cancer	0.00083	0.00136	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000818	0.00134	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000807	0.00132	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000799	0.00131	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000797	0.0013	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CRABP1—liver cancer	0.000792	0.00129	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HPGDS—liver cancer	0.000776	0.00127	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000771	0.00126	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000752	0.00123	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000741	0.00121	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.00073	0.00119	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—F2—liver cancer	0.000722	0.00118	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000713	0.00116	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000713	0.00116	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000711	0.00116	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000703	0.00115	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000703	0.00115	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000694	0.00113	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HPGDS—liver cancer	0.000692	0.00113	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PSMD10—liver cancer	0.000692	0.00113	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PSMA4—liver cancer	0.000692	0.00113	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000688	0.00112	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GOT2—liver cancer	0.000673	0.0011	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—F2—liver cancer	0.000644	0.00105	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2E1—liver cancer	0.000633	0.00103	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000627	0.00102	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000619	0.00101	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PSMA4—liver cancer	0.000617	0.00101	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PSMD10—liver cancer	0.000617	0.00101	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000612	0.001	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MMP2—liver cancer	0.000612	0.001	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—HRAS—liver cancer	0.000611	0.000998	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GOT2—liver cancer	0.0006	0.00098	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYCS—liver cancer	0.000592	0.000967	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GGT1—liver cancer	0.000581	0.000949	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GOT1—liver cancer	0.000581	0.000949	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2E1—liver cancer	0.000564	0.000922	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000546	0.000893	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MMP2—liver cancer	0.000546	0.000892	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—HRAS—liver cancer	0.000545	0.00089	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—UGDH—liver cancer	0.000533	0.000871	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYCS—liver cancer	0.000528	0.000863	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTP1—liver cancer	0.000522	0.000852	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GOT1—liver cancer	0.000518	0.000846	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GGT1—liver cancer	0.000518	0.000846	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HMOX1—liver cancer	0.000514	0.00084	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—EPT1—liver cancer	0.000501	0.000819	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTM1—liver cancer	0.000479	0.000783	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TAT—liver cancer	0.000475	0.000776	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CTNNB1—liver cancer	0.000469	0.000766	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTP1—liver cancer	0.000465	0.00076	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HMOX1—liver cancer	0.000459	0.00075	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1A1—liver cancer	0.000454	0.000742	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTM1—liver cancer	0.000428	0.000699	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—MTHFR—liver cancer	0.000424	0.000692	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CTNNB1—liver cancer	0.000419	0.000684	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARA—liver cancer	0.000416	0.000679	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1A1—liver cancer	0.000405	0.000662	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—MTHFR—liver cancer	0.000378	0.000617	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000373	0.00061	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARA—liver cancer	0.000371	0.000606	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CG—liver cancer	0.000356	0.000582	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARG—liver cancer	0.000344	0.000561	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000333	0.000544	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GLUL—liver cancer	0.000323	0.000528	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CPT1B—liver cancer	0.000323	0.000528	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CG—liver cancer	0.000318	0.000519	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CD—liver cancer	0.000313	0.000511	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NR1H4—liver cancer	0.000311	0.000509	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALB—liver cancer	0.000309	0.000505	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARG—liver cancer	0.000306	0.000501	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA3—liver cancer	0.000306	0.0005	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA4—liver cancer	0.00028	0.000457	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CD—liver cancer	0.000279	0.000456	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALB—liver cancer	0.000276	0.00045	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA2—liver cancer	0.000273	0.000446	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CB—liver cancer	0.000273	0.000446	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTA1—liver cancer	0.000263	0.00043	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NAT2—liver cancer	0.00026	0.000425	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALDOB—liver cancer	0.00025	0.000408	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CB—liver cancer	0.000243	0.000398	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CRABP1—liver cancer	0.000238	0.000389	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HPGDS—liver cancer	0.000208	0.00034	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSMD10—liver cancer	0.000185	0.000303	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSMA4—liver cancer	0.000185	0.000303	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GOT2—liver cancer	0.00018	0.000295	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2E1—liver cancer	0.00017	0.000277	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CA—liver cancer	0.000166	0.000272	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYCS—liver cancer	0.000159	0.000259	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GGT1—liver cancer	0.000156	0.000254	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GOT1—liver cancer	0.000156	0.000254	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CA—liver cancer	0.000148	0.000242	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTP1—liver cancer	0.00014	0.000229	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HMOX1—liver cancer	0.000138	0.000225	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—AKT1—liver cancer	0.000136	0.000222	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTM1—liver cancer	0.000129	0.00021	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1A1—liver cancer	0.000122	0.000199	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—AKT1—liver cancer	0.000121	0.000198	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—MTHFR—liver cancer	0.000114	0.000186	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARA—liver cancer	0.000111	0.000182	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CG—liver cancer	9.55e-05	0.000156	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARG—liver cancer	9.21e-05	0.000151	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CD—liver cancer	8.39e-05	0.000137	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALB—liver cancer	8.28e-05	0.000135	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CB—liver cancer	7.31e-05	0.000119	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.46e-05	7.28e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AKT1—liver cancer	3.64e-05	5.95e-05	CbGpPWpGaD
